A Study Comparing Blood Levels After Single-Dose Administration Of Artesunate Sachets (Pfizer) Versus Single-Dose Administration Of Arsuamoon® Tablets (Guilin-China) In Healthy Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Healthy Volunteers
Interventions
DRUG

artesunate sachets

single dose 50 mg (2 X 25 mg) artesunate sachets

DRUG

Arsuamoon

single dose 50 mg arsuamoon tablet

Trial Locations (1)

400709

Pfizer Investigational Site, Navi Mumbai

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY